» Articles » PMID: 34383799

Evaluation of Availability, Price, and Affordability of Cardiovascular, Diabetes, and Global Medicines in Abuja, Nigeria

Overview
Journal PLoS One
Date 2021 Aug 12
PMID 34383799
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To assess the availability, price, and affordability of cardiovascular, diabetes, and global medicines in Abuja, Nigeria.

Methods: A cross-sectional survey involving 27 private pharmacies, 13 public pharmacies, and 25 private hospital pharmacies in Abuja was conducted using the standardized World Health Organization/Health Action International methodology. The availability percentage for each pharmacy sector and each medicine was analyzed. The median price ratio (MPR) (ratio of the median price to the international reference prices) of the medicines were evaluated accordingly. Affordability was assessed by calculating the number of days' wages the lowest-paid unskilled government worker required to purchase a month worth of the standard treatment for a chronic condition.

Results: The availability of cardiovascular (CV) medicines ranged from 28.4% (in private hospital pharmacies) to 59.9% (in private pharmacies). There was mixed variability in the mean availability of Originator Brands (OBs) and Lowest Priced Generics (LPGs) anti-diabetic drugs with the highest availability being OBs 36% and LPGs 40.2%, in private pharmacies and public pharmacies, respectively. The availability of global drugs ranged from 49.7% in private hospitals to 68.8% in private pharmacies. Two cardiovascular and four global medicines had greater than 80% availability across the pharmaceutical sectors. The median price ratio for OBs and LPGs was 9.60 and 1.72 for procurement, it was 8.08 and 2.60 in private pharmacies, 13.56 and 2.66 in public hospitals, and 16.38 and 7.89 in private hospitals. The percentage markup on LPG was 49.4% in public hospitals, 51.4% in private pharmacies, and 323% in private hospitals. Only nine medicines in both public hospitals and private pharmacies and two in the private hospital pharmacies required less than the daily wage of the lowest-paid government worker.

Conclusion: The availability of cardiovascular, diabetes, and global medicines was below 80% across the different pharmaceutical sectors in Abuja and the medicines were unaffordable. Although the prices were generally exorbitant, private pharmacies offered the best options in terms of availability, pricing, and affordability of medicines. Therefore, the results of this study emphasize the pertinence of enforcing policies that facilitate the availability, pricing, and affordability of cardiovascular, diabetes, and global medicines.

Citing Articles

Availability and affordability of antidiabetic medicines in Herat of Afghanistan in 2023.

Tajik A, Varmaghani M, Ghavami V, Saeedi N, Sharifi F, Khajavi A J Diabetes Metab Disord. 2024; 23(2):1929-1940.

PMID: 39610474 PMC: 11599510. DOI: 10.1007/s40200-024-01444-0.


Managing medicines in decentralization: discrepancies between national policies and local practices in primary healthcare settings in Indonesia.

Fanda R, Probandari A, Kok M, Bal R Health Policy Plan. 2024; 40(3):346-357.

PMID: 39576064 PMC: 11886838. DOI: 10.1093/heapol/czae114.


Availability and Price Variations of Commonly Used Cardiovascular Medicines at Community and Hospital Pharmacies in Gondar Town, Northwest Ethiopia.

Limenh L, Tessema T, Sendekie A, Simegn W, Ayenew W, Mitku M Biomed Res Int. 2024; 2024:6551639.

PMID: 39318399 PMC: 11421931. DOI: 10.1155/2024/6551639.


Assessment of prices, availability and affordability of essential medicines in Juba County, South Sudan.

Deng J, Mayai A, Kayitare E, Ntakirutimana T, Swallehe O, Bizimana T J Pharm Policy Pract. 2023; 16(1):172.

PMID: 38158563 PMC: 10757353. DOI: 10.1186/s40545-023-00675-5.


Economic burden of non-communicable diseases on households in Nigeria: evidence from the Nigeria living standard survey 2018-19.

Odunyemi A, Rahman T, Alam K BMC Public Health. 2023; 23(1):1563.

PMID: 37592334 PMC: 10433548. DOI: 10.1186/s12889-023-16498-7.


References
1.
Dabare P, Wanigatunge C, Beneragama B . A national survey on availability, price and affordability of selected essential medicines for non communicable diseases in Sri Lanka. BMC Public Health. 2014; 14:817. PMC: 4138405. DOI: 10.1186/1471-2458-14-817. View

2.
Kaiser A, Hehman L, Forsberg B, Simangolwa W, Sundewall J . Availability, prices and affordability of essential medicines for treatment of diabetes and hypertension in private pharmacies in Zambia. PLoS One. 2019; 14(12):e0226169. PMC: 6910693. DOI: 10.1371/journal.pone.0226169. View

3.
Mendis S, Fukino K, Cameron A, Laing R, Filipe Jr A, Khatib O . The availability and affordability of selected essential medicines for chronic diseases in six low- and middle-income countries. Bull World Health Organ. 2007; 85(4):279-88. PMC: 2636320. DOI: 10.2471/blt.06.033647. View

4.
Hogerzeil H, Liberman J, Wirtz V, Kishore S, Selvaraj S, Kiddell-Monroe R . Promotion of access to essential medicines for non-communicable diseases: practical implications of the UN political declaration. Lancet. 2013; 381(9867):680-9. DOI: 10.1016/S0140-6736(12)62128-X. View

5.
Bertoldi A, Helfer A, Camargo A, Tavares N, Kanavos P . Is the Brazilian pharmaceutical policy ensuring population access to essential medicines?. Global Health. 2012; 8:6. PMC: 3511298. DOI: 10.1186/1744-8603-8-6. View